195 related articles for article (PubMed ID: 30428761)
1. Failure of tocilizumab in treating two patients with refractory SAPHO syndrome: a case report.
Sun XC; Liu S; Li C; Zhang S; Wang M; Shi XH; Hao WX; Zhang W
J Int Med Res; 2018 Dec; 46(12):5309-5315. PubMed ID: 30428761
[TBL] [Abstract][Full Text] [Related]
2. Acne fulminans with synovitis-acne-pustulosis-hyperostosis-osteitis (SAPHO) syndrome treated with infliximab.
Iqbal M; Kolodney MS
J Am Acad Dermatol; 2005 May; 52(5 Suppl 1):S118-20. PubMed ID: 15858507
[TBL] [Abstract][Full Text] [Related]
3. Biological treatments for SAPHO syndrome: an update.
Firinu D; Murgia G; Lorrai MM; Barca MP; Peralta MM; Manconi PE; del Giacco SR
Inflamm Allergy Drug Targets; 2014; 13(3):199-205. PubMed ID: 24846337
[TBL] [Abstract][Full Text] [Related]
4. SAPHO: has the time come for tailored therapy?
Figueiredo ASB; Oliveira AL; Caetano A; Moraes-Fontes MF
Clin Rheumatol; 2020 Jan; 39(1):177-187. PubMed ID: 31312988
[TBL] [Abstract][Full Text] [Related]
5. SAPHO Syndrome: Current Developments and Approaches to Clinical Treatment.
Firinu D; Garcia-Larsen V; Manconi PE; Del Giacco SR
Curr Rheumatol Rep; 2016 Jun; 18(6):35. PubMed ID: 27108452
[TBL] [Abstract][Full Text] [Related]
6. [Dermatologic aspects of SAPHO-syndrome].
Károlyi Z; Harhai I; Erós N
Orv Hetil; 2001 Aug; 142(33):1801-4. PubMed ID: 11573450
[TBL] [Abstract][Full Text] [Related]
7. Successful treatment of synovitis, acne, pustulosis, hyperostosis and osteitis syndrome with ixekizumab.
Xia R; Diao Z; Zhang Z; Liu J; Yin Z
Clin Exp Dermatol; 2022 May; 47(5):978-980. PubMed ID: 35089610
[TBL] [Abstract][Full Text] [Related]
8. Chronic recurrent multifocal osteomyelitis (CRMO) and synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome with associated neutrophilic dermatoses: a report of seven cases and review of the literature.
Tlougan BE; Podjasek JO; O'Haver J; Cordova KB; Nguyen XH; Tee R; Pinckard-Hansen KC; Hansen RC
Pediatr Dermatol; 2009; 26(5):497-505. PubMed ID: 19840301
[TBL] [Abstract][Full Text] [Related]
9. Rapid remission of refractory synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome in response to the Janus kinase inhibitor tofacitinib: A case report.
Li B; Li GW; Xue L; Chen YY
World J Clin Cases; 2020 Oct; 8(19):4527-4534. PubMed ID: 33083414
[TBL] [Abstract][Full Text] [Related]
10. Severe inflammation associated with synovitis, acne, pustulosis, hyperostosis, osteitis (SAPHO) syndrome was markedly ameliorated by single use of minocycline.
Takizawa Y; Murota A; Setoguchi K; Suzuki Y
Mod Rheumatol; 2014 Nov; 24(6):1015-8. PubMed ID: 24533553
[TBL] [Abstract][Full Text] [Related]
11. Ilium osteitis as the main manifestation of the SAPHO syndrome: response to infliximab therapy and review of the literature.
Moll C; Hernández MV; Cañete JD; Gómez-Puerta JA; Soriano A; Collado A; Sanmartí R
Semin Arthritis Rheum; 2008 Apr; 37(5):299-306. PubMed ID: 17976692
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment of a childhood synovitis, acne, pustulosis, hyperostosis and osteitis (SAPHO) syndrome with subcutaneous methotrexate: A case report.
Akçaboy M; Bakkaloğlu-Ezgü SA; Büyükkaragöz B; Isıyel E; Kandur Y; Hasanoğlu E; Buyan N
Turk J Pediatr; 2017; 59(2):184-188. PubMed ID: 29276872
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the immune response in the synovitis, acne, pustulosis, hyperostosis, osteitis (SAPHO) syndrome.
Hurtado-Nedelec M; Chollet-Martin S; Nicaise-Roland P; Grootenboer-Mignot S; Ruimy R; Meyer O; Hayem G
Rheumatology (Oxford); 2008 Aug; 47(8):1160-7. PubMed ID: 18559374
[TBL] [Abstract][Full Text] [Related]
14. Clinical features and radiological findings of 67 patients with SAPHO syndrome.
Okuno H; Watanuki M; Kuwahara Y; Sekiguchi A; Mori Y; Hitachi S; Miura K; Ogura K; Watanabe M; Hosaka M; Hatori M; Itoi E; Sato K
Mod Rheumatol; 2018 Jul; 28(4):703-708. PubMed ID: 28880693
[TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor-alpha blockers in SAPHO syndrome.
Ben Abdelghani K; Dran DG; Gottenberg JE; Morel J; Sibilia J; Combe B
J Rheumatol; 2010 Aug; 37(8):1699-704. PubMed ID: 20472920
[TBL] [Abstract][Full Text] [Related]
16. Synovitis, acne, pustulosis, hyperostosis and osteitis (SAPHO) syndrome with review of the relevant published work.
Zhao Z; Li Y; Li Y; Zhao H; Li H
J Dermatol; 2011 Feb; 38(2):155-9. PubMed ID: 21269311
[TBL] [Abstract][Full Text] [Related]
17. In SAPHO syndrome anti-TNF-alpha therapy may induce persistent amelioration of osteoarticular complaints, but may exacerbate cutaneous manifestations.
Massara A; Cavazzini PL; Trotta F
Rheumatology (Oxford); 2006 Jun; 45(6):730-3. PubMed ID: 16403830
[TBL] [Abstract][Full Text] [Related]
18. Successful treatment of SAPHO syndrome with apremilast.
Adamo S; Nilsson J; Krebs A; Steiner U; Cozzio A; French LE; Kolios AGA
Br J Dermatol; 2018 Oct; 179(4):959-962. PubMed ID: 29034454
[TBL] [Abstract][Full Text] [Related]
19. Gingival pustules and sterile diffuse sclerosing osteomyelitis as a feature of synovitis, acne, pustulosis, hyperostosis, osteitis (SAPHO) syndrome.
Chou A; Schulman JM; Gross AJ; Jordan RC; Ramos DM
Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 May; 121(5):e116-22. PubMed ID: 26619759
[TBL] [Abstract][Full Text] [Related]
20. Synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome - A challenging diagnosis not to be missed.
Zimmermann P; Curtis N
J Infect; 2016 Jul; 72 Suppl():S106-14. PubMed ID: 27263075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
